← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

TEM logoTempus AI, Inc.(TEM)Earnings, Financials & Key Ratios

TEM•NASDAQ
$53.50
$9.33B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutTempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.Show more
  • Revenue$1.27B+83.4%
  • EBITDA-$235M+64.1%
  • Net Income-$245M+65.3%
  • EPS (Diluted)-1.41+69.3%
  • Gross Margin69.64%+26.7%
  • EBITDA Margin-18.44%+80.4%
  • Operating Margin-18.76%+81.2%
  • Net Margin-19.27%+81.1%
  • ROE-89.48%+92.9%
  • ROIC-40.41%+85.7%
  • Debt/Equity1.66-80.0%
  • Interest Coverage-3.22+73.3%
Technical→

TEM Key Insights

Tempus AI, Inc. (TEM) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 46.6%

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 19.0x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

TEM Price & Volume

Tempus AI, Inc. (TEM) stock price & volume — 10-year historical chart

Loading chart...

TEM Growth Metrics

Tempus AI, Inc. (TEM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years46.57%
3 Years58.29%
TTM69.82%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM57.28%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM62.61%

Return on Capital

10 Years-56.33%
5 Years-63.6%
3 Years-70.52%
Last Year-18.81%

TEM Recent Earnings

Tempus AI, Inc. (TEM) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (75%)●Beat Revenue 6/12 qtrs (75%)
Q2 2026Latest
May 5, 2026
EPS
$0.13
Est $0.21
+38.1%
Revenue
$348M
Est $345M
+0.8%
Q1 2026
Feb 24, 2026
EPS
$0.04
Est $0.04
+8.8%
Revenue
$367M
Est $363M
+1.3%
Q4 2025
Nov 4, 2025
EPS
$0.11
Est $0.17
+36.2%
Revenue
$334M
Est $329M
+1.7%
Q3 2025
Aug 8, 2025
EPS
$0.22
Est $0.23
+4.3%
Revenue
$315M
Est $298M
+5.7%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.13vs $0.21+38.1%
$348Mvs $345M+0.8%
Q1 2026Feb 24, 2026
$0.04vs $0.04+8.8%
$367Mvs $363M+1.3%
Q4 2025Nov 4, 2025
$0.11vs $0.17+36.2%
$334Mvs $329M+1.7%
Q3 2025Aug 8, 2025
$0.22vs $0.23+4.3%
$315Mvs $298M+5.7%
Based on last 12 quarters of dataView full earnings history →

TEM Peer Comparison

Tempus AI, Inc. (TEM) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
EXAS logoEXASExact Sciences CorporationDirect Competitor20.02B104.91-95.3717.69%-6.4%-8.66%1.05
NTRA logoNTRANatera, Inc.Direct Competitor29.58B215.09-140.5856.75%-14.61%-24.69%0.16
VCYT logoVCYTVeracyte, Inc.Direct Competitor3.29B41.1950.2316.01%16.25%6.86%0.03
FLGT logoFLGTFulgent Genetics, Inc.Direct Competitor443.83M14.92-7.5713.83%-18.75%-5.42%0.00
ILMN logoILMNIllumina, Inc.Product Competitor21.66B142.5826.16-0.78%19.43%32.84%0.94
PACB logoPACBPacific Biosciences of California, Inc.Product Competitor516.17M1.71-1.60-23.19%-325.8%-13.95%1.33
CDNA logoCDNACareDx, IncProduct Competitor1.08B20.94-52.3513.79%-1.98%-2.61%0.06
ORCL logoORCLOracle CorporationSupply Chain557.72B193.9944.708.38%25.3%56.31%4.96

Compare TEM vs Peers

Tempus AI, Inc. (TEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs EXAS

Most directly comparable listed peer for TEM.

Scale Benchmark

vs ORCL

Larger-name benchmark to compare TEM against a more recognizable public peer.

Peer Set

Compare Top 5

vs EXAS, NTRA, VCYT, FLGT

TEM Income Statement

Tempus AI, Inc. (TEM) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue62.06M188M257.85M320.67M531.82M693.4M1.27B1.36B
Revenue Growth %-202.95%37.15%24.36%65.85%30.38%83.41%69.82%
Cost of Goods Sold46.02M159.29M174.21M190.48M245.65M312.29M386.1M386.53M
COGS % of Revenue74.15%84.73%67.56%59.4%46.19%45.04%30.36%-
Gross Profit
16.04M▲ 0%
28.71M▲ 79.0%
83.64M▲ 191.3%
130.19M▲ 55.6%
286.18M▲ 119.8%
381.11M▲ 33.2%
885.69M▲ 132.4%
977.64M▲ 0%
Gross Margin %25.85%15.27%32.44%40.6%53.81%54.96%69.64%71.67%
Gross Profit Growth %-78.99%191.3%55.64%119.82%33.17%132.39%-
Operating Expenses135.82M222.17M327.36M395.63M482.26M1.07B1.12B1.23B
OpEx % of Revenue218.87%118.17%126.95%123.38%90.68%154.63%88.4%-
Selling, General & Admin78.96M130.89M199M233.38M296.76M755.35M731.74M784.62M
SG&A % of Revenue127.24%69.62%77.18%72.78%55.8%108.93%57.54%-
Research & Development56.86M91.28M128.35M162.25M185.5M316.84M146.11M276.99M
R&D % of Revenue91.63%48.55%49.78%50.6%34.88%45.69%11.49%-
Other Operating Expenses000000246.48M2M
Operating Income
-119.78M▲ 0%
-193.45M▼ 61.5%
-243.71M▼ 26.0%
-265.44M▼ 8.9%
-196.08M▲ 26.1%
-691.08M▼ 252.4%
-238.63M▲ 65.5%
-254.66M▲ 0%
Operating Margin %-193.02%-102.9%-94.52%-82.78%-36.87%-99.67%-18.76%-18.67%
Operating Income Growth %--61.51%-25.98%-8.92%26.13%-252.44%65.47%-
EBITDA-104.76M-170.4M-219.83M-235.03M-162.75M-653.84M-234.55M-270.92M
EBITDA Margin %-168.81%-90.64%-85.25%-73.29%-30.6%-94.29%-18.44%-19.86%
EBITDA Growth %--62.66%-29.01%-6.92%30.75%-301.74%64.13%58.83%
D&A (Non-Cash Add-back)15.02M23.05M23.88M30.41M33.33M37.24M4.09M-16.27M
EBIT-114.92M-192.43M-243.4M-267.26M-166.66M-647.66M-226.44M-132.11M
Net Interest Income4.83M-17.43M-14.56M-18.86M-39.27M-42.57M-57.64M-126.05M
Interest Income4.86M1.5M623K3.03M7.6M11.08M12.63M14.68M
Interest Expense28K18.93M15.18M21.89M46.87M53.65M70.27M122.52M
Other Income/Expense4.83M-16.4M-15.48M-24.3M-17.75M-14.46M-58.08M-50.73M
Pretax Income
-114.95M▲ 0%
-209.85M▼ 82.6%
-259.19M▼ 23.5%
-289.75M▼ 11.8%
-213.83M▲ 26.2%
-705.54M▼ 230.0%
-296.71M▲ 57.9%
-305.39M▲ 0%
Pretax Margin %-185.23%-111.62%-100.52%-90.36%-40.21%-101.75%-23.33%-22.39%
Income Tax00066K288K266K-51.68M-5.44M
Effective Tax Rate %0%0%0%-0.02%-0.13%-0.04%17.42%1.78%
Net Income
-114.95M▲ 0%
-209.85M▼ 82.6%
-259.19M▼ 23.5%
-289.81M▼ 11.8%
-214.12M▲ 26.1%
-705.81M▼ 229.6%
-245.03M▲ 65.3%
-302.91M▲ 0%
Net Margin %-185.23%-111.62%-100.52%-90.38%-40.26%-101.79%-19.27%-22.2%
Net Income Growth %--82.56%-23.51%-11.81%26.12%-229.64%65.28%57.28%
Net Income (Continuing)-114.95M-209.85M-259.19M-289.81M-214.12M-705.81M-245.03M-302.91M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)
-0.92▲ 0%
-1.49▼ 62.0%
-1.75▼ 17.4%
-1.97▼ 12.6%
-1.73▲ 12.2%
-4.60▼ 165.9%
-1.41▲ 69.3%
-1.69▲ 0%
EPS Growth %--61.96%-17.45%-12.57%12.18%-165.9%69.35%62.61%
EPS (Basic)-0.92-1.49-1.75-1.97-1.73-4.60-1.41-
Diluted Shares Outstanding160.71M169.88M169.88M169.88M154.17M162.12M174.26M178.96M
Basic Shares Outstanding160.71M169.88M169.88M169.88M154.17M162.12M174.26M178.88M
Dividend Payout Ratio--------

TEM Balance Sheet

Tempus AI, Inc. (TEM) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets276.23M649.73M403.99M438.63M350.33M667.6M1.17B1.05B
Cash & Short-Term Investments227.6M513.44M277.69M302.94M197.57M448.26M755M639.07M
Cash Only227.6M513.44M277.69M302.94M165.77M340.95M604.79M521.17M
Short-Term Investments000031.81M107.31M150.21M117.9M
Accounts Receivable31.89M87.26M82.24M88.68M94.46M154.82M311.17M308.6M
Days Sales Outstanding187.56169.41116.42100.9464.8381.589.378.74
Inventory8.28M37.56M22.91M22.28M28.84M38.39M51.72M51.83M
Days Inventory Outstanding65.6786.064842.742.8644.8748.948.66
Other Current Assets8.47M11.48M21.15M24.73M29.45M26.14M49.28M54.44M
Total Non-Current Assets93.94M102.19M127.37M192.74M213.72M258.51M1.11B1.08B
Property, Plant & Equipment36.06M38.44M35.4M67.79M82.21M72.82M153.65M150.9M
Fixed Asset Turnover1.72x4.89x7.29x4.73x6.47x9.52x8.28x9.20x
Goodwill15.99M15.99M15.98M53.1M73.35M73.34M470.21M470.17M
Intangible Assets41.33M44.46M37.29M37.28M21.92M11.72M355.25M330.59M
Long-Term Investments0000091.45M21.11M236.36M
Other Non-Current Assets558K3.3M38.7M34.57M36.24M9.19M107.44M297.56M
Total Assets
370.17M▲ 0%
751.92M▲ 103.1%
531.35M▼ 29.3%
631.36M▲ 18.8%
564.05M▼ 10.7%
926.12M▲ 64.2%
2.27B▲ 145.6%
2.14B▲ 0%
Asset Turnover0.17x0.25x0.49x0.51x0.94x0.75x0.56x0.66x
Asset Growth %-103.13%-29.33%18.82%-10.66%64.19%145.63%406.76%
Total Current Liabilities43.73M101.38M114.81M174.24M232.63M291.07M372.39M317.96M
Accounts Payable13.41M53.57M33.75M45.99M54.42M53.8M81.99M41.02M
Days Payables Outstanding106.41122.7570.7288.1280.8662.8977.5161.83
Short-Term Debt00000013.36M12.64M
Deferred Revenue (Current)5.57M6.96M16.45M50.14M64.86M91.94M92.67M382.64M
Other Current Liabilities5.72M14.01M22.33M24.73M30.16M31.73M184.37M191.43M
Current Ratio6.32x6.41x3.52x2.52x1.51x2.29x3.13x3.13x
Quick Ratio6.13x6.04x3.32x2.39x1.38x2.16x3.00x3.00x
Cash Conversion Cycle146.82132.7193.755.5226.8363.4860.6965.58
Total Non-Current Liabilities580.85M1.16B1.22B1.59B1.71B578.71M1.41B1.4B
Long-Term Debt0250M238.24M389.55M449.67M435.44M802.35M801.99M
Capital Lease Obligations1.44M724K291K37.13M32.04M26.2M0123.59M
Deferred Tax Liabilities00000000
Other Non-Current Liabilities579.41M912.8M985.51M1.12B1.22B86.43M608.77M1.29B
Total Liabilities624.59M1.26B1.34B1.76B1.95B869.78M1.78B1.72B
Total Debt2.59M251.45M238.95M433.03M488.14M468.09M815.71M814.63M
Net Debt-225.01M-261.99M-38.74M130.09M322.38M127.14M210.92M293.46M
Debt / Equity-----8.31x1.66x1.66x
Debt / EBITDA--------3.01x
Net Debt / EBITDA--------1.08x
Interest Coverage-4104.39x-10.17x-16.03x-12.21x-3.56x-12.07x-3.22x-1.08x
Total Equity
-254.41M▲ 0%
-512.98M▼ 101.6%
-807.49M▼ 57.4%
-1.13B▼ 39.8%
-1.38B▼ 22.4%
56.34M▲ 104.1%
491.33M▲ 772.1%
416.4M▲ 0%
Equity Growth %--101.63%-57.41%-39.82%-22.42%104.08%772.09%1859.99%
Book Value per Share-1.58-3.02-4.75-6.65-8.960.352.822.33
Total Shareholders' Equity-254.41M-512.98M-807.49M-1.13B-1.38B56.34M491.33M416.4M
Common Stock6K6K6K6K6K17K00
Retained Earnings-257.85M-512.99M-807.49M-1.14B-1.4B-2.15B00
Treasury Stock0000-3.6M-3.6M00
Accumulated OCI1K-1K-11K18K5K94K00
Minority Interest00000000

TEM Cash Flow Statement

Tempus AI, Inc. (TEM) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-117.11M-206.56M-211.98M-168.2M-214.34M-189.04M-218.09M-218.09M
Operating CF Margin %-188.72%-109.87%-82.21%-52.45%-40.3%-27.26%-17.15%-
Operating CF Growth %--76.38%-2.62%20.65%-27.43%11.8%-15.36%-163.87%
Net Income-114.95M-209.85M-259.19M-289.81M-214.12M-705.81M-245.03M-302.91M
Depreciation & Amortization15.02M23.05M23.88M30.41M33.33M37.24M4.09M84.93M
Stock-Based Compensation529K399K559K00534.14M124.75M154.48M
Deferred Taxes000000-52.66M-6.45M
Other Non-Cash Items3.65M15.29M8.22M19.38M4.28M-16.82M129.31M-61.3M
Working Capital Changes-21.36M-35.45M14.55M71.82M-37.84M-37.8M-178.55M-54.49M
Change in Receivables-13.37M-55.84M4.75M-8.2M-7.35M-61.04M-90.4M-43.24M
Change in Inventory-3.47M-29.28M14.65M-1.31M-6.56M-9.54M-3.37M-2.79M
Change in Payables038.13M-30.47M-7.92M-23.36M-23.85M-7.24M-55.81M
Cash from Investing-43.03M-13.42M-21.72M-57.94M-40.31M-130.39M-398.36M-22.54M
Capital Expenditures-17.04M-13.42M-11.77M-18.38M-34.61M-22.12M-27.27M-18.98M
CapEx % of Revenue27.45%7.14%4.56%5.73%6.51%3.19%2.14%-
Acquisitions-25.99M0-5.96M-39.56M-5.71M-95.19M-376.67M4.1M
Investments--------
Other Investing00-4M0000-4.92M
Cash from Financing196.69M506.11M-2.04M251.39M117.55M494.33M884.12M591.08M
Debt Issued (Net)-919K329.11M-796K170.25M82.59M0735.76M726.5M
Equity Issued (Net)202.9M182.62M8.89M92.2M41.28M579.45M192.46M-3.04M
Dividends Paid-5.29M-5.63M-5.63M-5.63M-5.63M-5.63M00
Share Repurchases0-7.31M00-3.6M0-3.04M-3.04M
Other Financing00-4.51M-5.43M-698K-79.5M-44.1M-132.38M
Net Change in Cash
36.54M▲ 0%
286.12M▲ 682.9%
-235.75M▼ 182.4%
25.27M▲ 110.7%
-137.12M▼ 642.7%
175.23M▲ 227.8%
263.83M▲ 50.6%
456.13M▲ 0%
Free Cash Flow
-134.15M▲ 0%
-219.98M▼ 64.0%
-223.75M▼ 1.7%
-186.58M▲ 16.6%
-248.95M▼ 33.4%
-211.17M▲ 15.2%
-239.14M▼ 13.2%
-208.3M▲ 0%
FCF Margin %-216.17%-117.01%-86.77%-58.19%-46.81%-30.45%-18.8%-15.27%
FCF Growth %--63.98%-1.72%16.61%-33.43%15.18%-13.25%2.06%
FCF per Share-0.83-1.29-1.32-1.10-1.61-1.30-1.37-1.37
FCF Conversion (FCF/Net Income)1.02x0.98x0.82x0.58x1.00x0.27x0.89x0.69x
Interest Paid02.05M80K4.66M16.91M28.05M026.5M
Taxes Paid08K3K6K161K206K0136K

TEM Key Ratios

Tempus AI, Inc. (TEM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)-----1252.79%-89.48%-70.24%
Return on Invested Capital (ROIC)-----282.49%-40.41%-40.41%
Gross Margin15.27%32.44%40.6%53.81%54.96%69.64%71.67%
Net Margin-111.62%-100.52%-90.38%-40.26%-101.79%-19.27%-22.2%
Debt / Equity----8.31x1.66x1.66x
Interest Coverage-10.17x-16.03x-12.21x-3.56x-12.07x-3.22x-1.08x
FCF Conversion0.98x0.82x0.58x1.00x0.27x0.89x0.69x
Revenue Growth202.95%37.15%24.36%65.85%30.38%83.41%69.82%

TEM SEC Filings & Documents

Tempus AI, Inc. (TEM) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 24, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 24, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 8, 2025·SEC

TEM Frequently Asked Questions

Tempus AI, Inc. (TEM) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Tempus AI, Inc. (TEM) reported $1.36B in revenue for fiscal year 2025. This represents a 2098% increase from $62.1M in 2019.

Tempus AI, Inc. (TEM) grew revenue by 83.4% over the past year. This is strong growth.

Tempus AI, Inc. (TEM) reported a net loss of $302.9M for fiscal year 2025.

Dividend & Returns

Tempus AI, Inc. (TEM) has a return on equity (ROE) of -89.5%. Negative ROE indicates the company is unprofitable.

Tempus AI, Inc. (TEM) had negative free cash flow of $208.3M in fiscal year 2025, likely due to heavy capital investments.

Explore More TEM

Tempus AI, Inc. (TEM) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.